Adrian Adams

2017 - Aralez Pharmaceuticals

In 2017, Adrian Adams earned a total compensation of $2.1M as Chief Executive Officer at Aralez Pharmaceuticals, a 74% decrease compared to previous year.

Compensation breakdown

Option Awards$228,005
Salary$721,000
Stock Awards$1,138,108
Other$12,000
Total$2,099,113

Adams received $1.1M in stock awards, accounting for 54% of the total pay in 2017.

Adams also received $228K in option awards, $721K in salary and $12K in other compensation.

Rankings

In 2017, Adrian Adams' compensation ranked 5,273rd out of 14,666 executives tracked by ExecPay. In other words, Adams earned more than 64.0% of executives.

ClassificationRankingPercentile
All
5,273
out of 14,666
64th
Division
Manufacturing
1,881
out of 5,768
67th
Major group
Chemicals And Allied Products
557
out of 2,074
73rd
Industry group
Drugs
430
out of 1,730
75th
Industry
Pharmaceutical Preparations
339
out of 1,329
75th
Source: SEC filing on May 18, 2018.

Adams' colleagues

We found five more compensation records of executives who worked with Adrian Adams at Aralez Pharmaceuticals in 2017.

2017

Scott Charles

Aralez Pharmaceuticals

Chief Financial Officer

2017

Andrew Koven

Aralez Pharmaceuticals

President and Chief Business Officer

2017

James Tursi

Aralez Pharmaceuticals

Chief Medical Officer

2017

Mark Glickman

Aralez Pharmaceuticals

Former Chief Commercial Officer

2017

Michael Kaseta

Aralez Pharmaceuticals

Chief Financial Officer

News

You may also like